Scilex Holding Co (SCLX)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Henry Ji - OfficerHenry Ji - OfficerHenry Ji - OfficerScilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Other acquisition / disposition | 1 | 500,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
22 Form 4 filings on record, the earliest from Oct 17, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | Other | Common stock | 500,000 | - | - | |
| Stephen Hoi Ma - Officer | Open-market purchase | Warrant (right to buy) | 650,000 | $0.15 | $100K | |
| Henry Ji - Officer | Open-market purchase | Warrant (right to buy) | 3,250,000 | $0.15 | $500K | |
| Henry Ji - Officer | Open-market sale | Warrant (right to buy) | 650,000 | $0.15 | $100K | |
| Scilex Holding Co | Open-market sale | Common Stock | 3,689,016 | $0.75 | $2.77M | |
| Scilex Holding Co | Open-market sale | Common Stock | 7,310,984 | $0.66 | $4.79M | |
| Scilex Holding Co | Open-market sale | Common Stock | 9,657,300 | $0.54 | $5.21M | |
| Jay Chun | Grant or award | Nonstatutory Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Yue Alexander Wu | Grant or award | Nonstatutory Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Dorman Followwill | Grant or award | Nonstatutory Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Henry Ji - Officer | Grant or award | Incentive Stock Option (right to buy) | 120,000 | $0.00 | - | |
| Stephen Hoi Ma - Officer | Grant or award | Incentive Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Jaisim Shah - Officer | Open-market purchase | Common Stock | 30,000 | $16.10 | $14K | |
| Dorman Followwill | Grant or award | Nonstatutory Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Jay Chun | Grant or award | Nonstatutory Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Yue Alexander Wu | Grant or award | Nonstatutory Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Henry Ji - Officer | Open-market purchase | Common Stock | 8,888 | $32.89 | $8K | |
| Jaisim Shah - Officer | Open-market purchase | Common Stock | 32,000 | $34.64 | $32K | |
| Yue Alexander Wu | Open-market purchase | Common Stock | 20,000 | $33.24 | $19K | |
| David Lemus | Open-market purchase | Common Stock | 2,000 | $31.50 | $2K | |
| Henry Ji - Officer | Open-market purchase | Common Stock | 10,000 | $33.99 | $10K | |
| Jay Chun | Open-market purchase | Common Stock | 5,000 | $33.25 | $5K | |
| Dorman Followwill | Open-market purchase | Common Stock | 1,000 | $34.65 | $990 | |
| Jaisim Shah - Officer | Open-market purchase | Common Stock | 30,000 | $34.71 | $30K | |
| Stephen Hoi Ma - Officer | Open-market purchase | Common Stock | 6,700 | $33.95 | $6K |
Scilex Holding Co (SCLX) had 1 insider filing in the last 90 days, with the most recent on 2026-07-08. The full record for SCLX runs to 22 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of SCLX were filed in the last 90 days. 12 purchases are on record for this company.
No insider sales of SCLX were filed in the last 90 days. 4 sales are on record for this company.
This page tracks SCLX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add SCLX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
